News | Artificial Intelligence | November 30, 2020

FDA Clears AI-Rad Companion Organs RT Intelligent Software Assistant from Siemens Healthineers

AI-based software automates contouring process for organs at risk during radiation therapy planning

During the virtual 106th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 29 to Dec. 5, Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of AI-Rad Companion Organs RT, the latest Siemens Healthineers artificial intelligence-based software assistant in the AI-Rad Companion family.

November 30, 2020 — During the virtual 106th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 29 to Dec. 5, Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of AI-Rad Companion Organs RT, the latest Siemens Healthineers artificial intelligence-based software assistant in the AI-Rad Companion family. AI-Rad Companion Organs RT uses deep-learning AI algorithms to automatically contour organs at risk (OARs) on computed tomography (CT) images as part of the radiation therapy planning workflow and helps facilitate precision medicine.

Identifying and contouring a patient’s normal organ anatomy on CT-based planning images is critical to ensuring the appropriate radiation dose to targeted organs and the minimum level of exposure for normal tissue. Historically, manual contouring is a time-consuming, slice-by-CT-slice process that also can lack consistency, as contours may differ with each radiation therapist or when recontouring.

The deep-learning algorithms of AI-Rad Companion Organs RT automate this contouring process for various body regions, including the head and neck, thorax, abdomen, and pelvic regions, to accelerate contouring. AI-Rad Companion Organs RT also supports the use of organ template configurations that can be aligned with institutional protocols, which may save time and improve standardization in clinical workflows.

“AI-Rad Companion Organs RT provides the radiation therapist with AI-powered organ contouring for a potentially significant reduction in turnaround time,” said Peter Shen, Vice President of Innovation and Digital Business at Siemens Healthineers North America. “AI-Rad Companion Organs RT reinforces the multi-modality and multi-organ approach that Siemens Healthineers has employed with our rapidly expanding AI-Rad Companion family of intelligent software assistants.”

AI-Rad Companion Organs RT is available on the teamplay cloud-based digital health platform from Siemens Healthineers. Like the other software assistants in the AI-Rad Companion family, it is seamlessly integrated into the existing clinical workflow and is DICOM (Digital Imaging and Communications in Medicine) compliant.

For more information: siemens-healthineers.us/ai-rad

Related Content

Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
News | Contrast Media Injectors | February 25, 2021
February 25, 2021 — Guerbet announced the launch of ...
Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global market
News | Magnetic Resonance Imaging (MRI) | February 24, 2021
February 24, 2021 — Frost & Sullivan's recent analysis, Technological Advancements and Emerging Applications in t
55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned. #COVIDvaccine #COVID19

55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned.

News | Breast Imaging | February 24, 2021
Detroit-based magnetic resonance imaging (MRI) technology company SpinTech, Inc. has acquired medical-imaging research and technology developer Magnetic Resonance Innovations, Inc. (MR Innovations).
News | Magnetic Resonance Imaging (MRI) | February 24, 2021
February 24, 2021 — Detroit-based magnetic resonance...
Findings indicate that PPC and GG are highly predictive of overall upstaging by PSMA PET/CT for patients with high-risk prostate cancer

Image courtesy of UCLA Health

News | PET-CT | February 23, 2021
February 23, 2021 — A...
icobrain cva allows the quantitative assessment of tissue perfusion by reporting the volume of core and perfusion lesion by quantifying Tmax abnormality and CBF abnormality together with the mismatch volume and ratio
News | Artificial Intelligence | February 23, 2021
February 23, 2021 — icometrix, world leader in imaging...
Dr Sahar Saleem placing the mummy in the CT scanner

Dr. Sahar Saleem placing the mummy in the CT scanner. Image courtesy of Sahar Saleem

News | Computed Tomography (CT) | February 22, 2021
February 22, 2021 — Modern medical technology is helping scholars tell a more nuanced story about the fate of an anci